Eli Lilly

HHS general counsel scolds Eli Lilly for halting 340B drug discounts
HHS general counsel scolds Eli Lilly for halting 340B drug discounts
Beckers Hospital Review
HHS
Eli Lilly
340B
hospitals
discounts
Flag link:
ESMO: Lilly's Verzenio pressures Pfizer with practice-changing win in early breast cancer
ESMO: Lilly's Verzenio pressures Pfizer with practice-changing win in early breast cancer
Fierce Pharma
Ibrance
Pfizer
Eli Lilly
Verzenio
breast cancer
ESMO
Flag link:
Eli Lilly, Amgen join forces to scale production of COVID-19 antibody cocktails
Eli Lilly, Amgen join forces to scale production of COVID-19 antibody cocktails
Fierce Pharma
Eli Lilly
Amgen
LY-CoV-55
antibody cocktail
COVID-19
Flag link:
Combo study of Gilead antiviral, Lilly anti-inflammatory drug positive in Covid-19, but raises pricing jitters
Combo study of Gilead antiviral, Lilly anti-inflammatory drug positive in Covid-19, but raises pricing jitters
MedCity News
Eli Lilly
olumiant
Gilead Sciences
remdesivir
Veklury
drug pricing
COVID-19
Flag link:
Lilly offers first evidence that its antibody drug may help treat COVID-19
Lilly offers first evidence that its antibody drug may help treat COVID-19
BioPharma Dive
Eli Lilly
AbCellera
antibodies
COVID-19
clinical trial
Flag link:
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
Shares of Lilly and Incyte gain after late-stage study finds their arthritis drug can help reduce COVID-19 recovery time
Marketwatch
Eli Lilly
Incyte
olumiant
COVID-19
remdesivir
Gilead Sciences
Flag link:
Eli Lilly, squaring off against AbbVie and Biohaven, touts data showing early and lasting migraine relief from Reyvow
Eli Lilly, squaring off against AbbVie and Biohaven, touts data showing early and lasting migraine relief from Reyvow
Fierce Pharma
Eli Lilly
migraines
clinical trials
Reyvow
Biohaven
AbbVie
Flag link:
Eli Lilly stops giving 340B discounts to contract pharmacies
Eli Lilly stops giving 340B discounts to contract pharmacies
Beckers Hospital Review
Eli Lilly
340B
contract pharmacies
hospitals
Flag link:
ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit
ESC 2020 – Jardiance joins Farxiga in showing heart failure benefit
EP Vantage
ESC
Eli Lilly
Boehringer Ingelheim
Farxiga
Jardiance
heart failure
AstraZeneca
Flag link:
Lilly Asia Ventures leads AstraZeneca spinout's $100M push into China's growing R&D hub in Wuxi
Lilly Asia Ventures leads AstraZeneca spinout's $100M push into China's growing R&D hub in Wuxi
Endpoints
Eli Lilly
Lilly Asia Ventures
AstraZeneca
China
R&D
Dizal Pharmaceutical
Flag link:
Eli Lilly Strikes $1 Billion Deal with Innovent for Checkpoint Inhibitor
Eli Lilly Strikes $1 Billion Deal with Innovent for Checkpoint Inhibitor
BioSpace
Eli Lilly
Innovent Biologics
China
immuno-oncology
Flag link:
These 4 Drugmakers Are Using AI to Improve Their Products. Does It Make Them Better Buys?
These 4 Drugmakers Are Using AI to Improve Their Products. Does It Make Them Better Buys?
Motley Fool
artificial intelligence
drug development
AstraZeneca
GSK
Novartis
Eli Lilly
Flag link:
Five Top Drugmakers Reveal List vs. Net Price Gaps
Five Top Drugmakers Reveal List vs. Net Price Gaps
Drug Channels
Eli Lilly
Janssen
Merck
Novartis
Sanofi
drug pricing
Flag link:
Pieris begins gastric cancer combination trial with Lilly’s Cyramza
Pieris begins gastric cancer combination trial with Lilly’s Cyramza
Pharmaforum
Pieris
Eli Lilly
PRS-343
Cyramza
gastric cancer
clinical trial
Flag link:
Teva's Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout
Teva's Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout
Fierce Pharma
Teva Pharmaceutical
migraines
Ajovy
autoinjectors
Amgen
Eli Lilly
Flag link:
WCLC: Lilly, Innovent tout Tyvyt front-line lung cancer win. Can it challenge Merck’s Keytruda?
WCLC: Lilly, Innovent tout Tyvyt front-line lung cancer win. Can it challenge Merck’s Keytruda?
Fierce Pharma
Eli Lilly
Innovent Biologics
China
non-small cell lung cancer
Tyvyt
Merck
Keytruda
Flag link:
Karuna and Incyte scrap programs; More cash for the SPACs
Karuna and Incyte scrap programs; More cash for the SPACs
Endpoints
Karuna Therapeutics
Eli Lilly
Incyte
SPAC
Flag link:
Lilly to test COVID-19 antibody drug in unorthodox nursing home study
Lilly to test COVID-19 antibody drug in unorthodox nursing home study
BioPharma Dive
Eli Lilly
clinical trials
antibodies
nursing homes
COVID-19
Flag link:
Boehringer and Lilly’s Jardiance Hits Mark in Decreasing Risk of Death in Heart Failure
Boehringer and Lilly’s Jardiance Hits Mark in Decreasing Risk of Death in Heart Failure
BioSpace
Boehringer Ingelheim
Eli Lilly
Jardiance
heart failure
diabetes
clinical trials
Flag link:
Eli Lilly's stock rallies after a profit beat and raised outlook, although revenue fell short
Eli Lilly's stock rallies after a profit beat and raised outlook, although revenue fell short
Marketwatch
earnings
Eli Lilly
Flag link:

Pages